Ying et al. [30] found that the positive expression rates of PI3K, p-AKT, and p-mTOR in gastric cancer were 49%, 58%, and 56%, respectively, and gastric cancer patients with PI3K/p-AKT/p-mTOR had a poor prognosis. The gene discussed is MTOR; the disease is gastric cancer.